← back to search

Diana Bharucha‐Goebel

Nationwide Children's Hospital ·
Area of research
Molecular Biology · Genetics
Research interest
Research interests include Muscle Physiology and Disorders, Neurogenetic and Muscular Disorders Research, Hereditary Neurological Disorders, and Cardiomyopathy and Myosin Studies.
h-index
24
citations
2,491
works
101
NIH funding
primary concept
email

Recent publications

Current clinical applications of AAV-mediated gene therapy
Molecular Therapy 2025cited by 59position: middledoi
Access to novel therapies for Duchenne muscular dystrophy—Insights from expert treating physicians
Annals of the Child Neurology Society 2024cited by 6position: middledoi
Intermediate filament dysregulation in astrocytes in the human disease model of <i>KLHL16</i> mutation in giant axonal neuropathy (GAN)
Molecular Biology of the Cell 2023cited by 7position: middledoi
Intermediate filament dysregulation and astrocytopathy in the human disease model of <i>KLHL16</i> mutation in giant axonal neuropathy (GAN)
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 1position: middledoi
Cardiac and pulmonary findings in dysferlinopathy: A 3‐year, longitudinal study
Muscle & Nerve 2022cited by 21position: middledoi
Water T2 could predict functional decline in patients with dysferlinopathy
Journal of Cachexia Sarcopenia and Muscle 2022cited by 20position: middledoi
Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease
Neuromuscular Disorders 2021cited by 64position: middledoi
Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale
Annals of Neurology 2021cited by 35position: middledoi
Congenital Titinopathy: Comprehensive characterization and pathogenic insights
Annals of Neurology 2018cited by 160position: middledoi
Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials
Journal of Neurology Neurosurgery & Psychiatry 2018cited by 116position: middledoi
Examining longitudinal functional changes in Dysferlinopathy: The JAIN Clinical Outcome Study (P5.429)
Neurology 2018cited by 0position: middledoi
The Role of <i>PIEZO2</i> in Human Mechanosensation
New England Journal of Medicine 2016cited by 467position: middledoi
Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy
Acta Neuropathologica 2016cited by 135position: middledoi
The Clinical Outcome Study for dysferlinopathy
Neurology Genetics 2016cited by 110position: middledoi
Peripheral motor neuropathy is associated with defective kinase regulation of the KCC3 cotransporter
Science Signaling 2016cited by 54position: middledoi
Severe congenital <i>RYR1</i> -associated myopathy
Neurology 2013cited by 108position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Carsten G. Bönnemann · National Institutes of Health5 papers (2013–2023)Tanya Stojkovic · University of Padua2 papers (2018–2022)Volker Straub · ZHAW Zurich University of Applied Sciences2 papers (2018–2022) · 2 papers (2018–2022)Alan Pestronk · Ludwig-Maximilians-Universität München2 papers (2018–2022)Sandra Donkervoort · Government of the United States of America2 papers (2016–2016)Kristi Jones · Murdoch Children's Research Institute2 papers (2018–2022) · 2 papers (2023–2023)Emmanuelle Salort‐Campana · Ludwig-Maximilians-Universität München2 papers (2018–2022)Diane Armao · Gene Therapy Laboratory2 papers (2023–2023) · 2 papers (2023–2023)Jerry R. Mendell · Nationwide Children's Hospital2 papers (2018–2022) · 2 papers (2023–2023) · 2 papers (2018–2022)Maryam Faridounnia · Utrecht University2 papers (2023–2023)Anna Mayhew · Newcastle University2 papers (2018–2022)Jody E. Hooper · Palo Alto University2 papers (2023–2023)Adriana S. Beltrán · Medical College of Wisconsin2 papers (2023–2023)Thomas W. Bouldin · National Institute of Neurological Disorders and Stroke2 papers (2023–2023)Jordi Díaz‐Manera · Universitat de Barcelona2 papers (2018–2022)